AlzChem Group AG/€ACT
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About AlzChem Group AG
AlzChem Group AG is a German company that operates in the specialty chemicals industry. The company focuses on the development, production, and distribution of chemical products utilized in various applications, including agriculture, nutrition, and fine chemicals. AlzChem Group offers a range of products, such as creatine for nutritional purposes, cyanamide for agricultural uses, and nitrile compounds used in pharmaceuticals. Headquartered in Trostberg, Germany, the company serves markets globally through its network of facilities and distribution partners. AlzChem's strategic positioning is bolstered by its expertise in niche chemical applications and its strong emphasis on research and development to meet diverse market needs.
Ticker
€ACT
Sector
Primary listing
XETRA
Industry
Chemicals
Headquarters
Employees
1,647
ISIN
DE000A2YNT30
Website
AlzChem Group AG Metrics
BasicAdvanced
€1.4B
24.81
€5.55
0.81
€1.80
1.31%
Price and volume
Market cap
€1.4B
Beta
0.81
52-week high
€139.80
52-week low
€39.84
Average daily volume
43K
Dividend rate
€1.80
Financial strength
Current ratio
2.712
Quick ratio
1.764
Dividend payout ratio (TTM)
21.62%
Interest coverage (TTM)
31.13%
Profitability
EBITDA (TTM)
100.889
Gross margin (TTM)
62.84%
Net profit margin (TTM)
10.09%
Operating margin (TTM)
13.82%
Effective tax rate (TTM)
27.72%
Revenue per employee (TTM)
€340,000
Management effectiveness
Return on assets (TTM)
9.63%
Return on equity (TTM)
28.19%
Valuation
Price to earnings (TTM)
24.808
Price to revenue (TTM)
2.503
Price to book
6.3
Price to tangible book (TTM)
6.41
Price to free cash flow (TTM)
17.935
Free cash flow yield (TTM)
5.58%
Free cash flow per share (TTM)
767.76%
Dividend yield (TTM)
1.31%
Forward dividend yield
1.31%
Growth
Revenue change (TTM)
2.17%
Earnings per share change (TTM)
44.29%
3-year revenue growth (CAGR)
7.23%
3-year earnings per share growth (CAGR)
27.11%
3-year dividend per share growth (CAGR)
21.64%
Bulls say / Bears say
AlzChem Group AG reported a record EBITDA of EUR 105.3 million for fiscal year 2024, marking a 29.4% increase from the previous year, indicating strong operational performance. (finanzwire.com)
The company increased its dividend by 50% to EUR 1.80 per share, reflecting confidence in its financial health and commitment to shareholder returns. (rttnews.com)
AlzChem's inclusion in the SDAX index on October 2, 2024, enhances its visibility and may attract more institutional investors. (benzinga.com)
The Basics & Intermediates segment experienced a 9.5% decline in sales in 2024, which could indicate challenges in this market segment. (finanzwire.com)
Despite overall growth, the company faces strong competition and general industry downturns, particularly affecting the Basics & Intermediates segment. (finanzwire.com)
The company's plan to buy back shares for up to EUR 6 million may indicate a lack of profitable reinvestment opportunities, potentially affecting future growth. (benzinga.com)
Data summarised monthly by Lightyear AI. Last updated on 27 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AlzChem Group AG stock?
AlzChem Group AG (ACT) has a market cap of €1.4B as of July 02, 2025.
What is the P/E ratio for AlzChem Group AG stock?
The price to earnings (P/E) ratio for AlzChem Group AG (ACT) stock is 24.81 as of July 02, 2025.
Does AlzChem Group AG stock pay dividends?
Yes, the AlzChem Group AG (ACT) stock pays dividends to shareholders. As of July 02, 2025, the dividend rate is €1.8 and the yield is 1.31%. AlzChem Group AG has a payout ratio of 21.62% on a trailing twelve-month basis.
When is the next AlzChem Group AG dividend payment date?
The next AlzChem Group AG (ACT) dividend payment date is unconfirmed.
What is the beta indicator for AlzChem Group AG?
AlzChem Group AG (ACT) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.